Candice French has nearly 12 years of industry experience, including in-depth experience in CNS indications. Ms. French has spent three years focused on Alzheimer’s Disease and has five years of combined experience with Schizoaffective Disorder and Major Depressive Disorder. Ms. French is familiar with a large variety of cognitive and neuropsychological tests, symptom rating scales and many other diagnostic and efficacy assessments such as specialty labs, lumbar puncture and various imaging procedures. Ms. French is accustomed to overcoming the unique challenges of these complex neurological and psychiatric indications, including patient retention and compliance. Ms. French has experience managing all phases of clinical trials in various positions including Project Manager, Clinical Team Lead and Clinical Research Associate, and over the course of her career, she has successfully led trials of varying sizes and complexity, both domestically and internationally. She is a purpose-driven leader with high attention to detail and strong communication skills. She received her BS in Psychology from The University of Arizona.

Why Clinical Research?

“I happened upon an ad for a CRA internship out of college and though I had very little knowledge of the industry, I was charmed by the prospect of making a living wage while travelling. I quickly fell in love with clinical research, specifically captivated by the opportunity to continuously learn about a variety of diseases and drugs. The ever-changing landscape of clinical operations perfectly fulfills my desire for constant knowledge and change, with each protocol, site and subject presenting unique challenges to overcome.”

This is what drives Candice:

“The human mind has always fascinated me and drove me to major in Psychology in college. With CNS trials, I am especially intrigued by the various scales that are typically administered as I feel like I get a glimpse into the patients’ most inner thoughts and feelings, who they truly are. I have seen firsthand how devastating many of the diseases that affect those inner workings can be, and I am passionate about helping to bring new therapies to improve these patients’ lives.”